| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 174.52B | 170.29B | 173.88B | 174.84B | 126.96B |
| Gross Profit | 55.01B | 50.37B | 49.09B | 44.94B | 37.00B |
| EBITDA | 16.44B | 29.81B | 30.28B | 27.77B | 21.25B |
| Net Income | 11.53B | 10.40B | 11.63B | 9.96B | 5.24B |
Balance Sheet | |||||
| Total Assets | 198.20B | 197.84B | 188.36B | 185.37B | 161.88B |
| Cash, Cash Equivalents and Short-Term Investments | 9.80B | 11.32B | 9.47B | 2.72B | 9.57B |
| Total Debt | 52.61B | 51.66B | 62.73B | 68.09B | 58.81B |
| Total Liabilities | 98.49B | 109.35B | 109.35B | 117.37B | 102.68B |
| Stockholders Equity | 97.42B | 86.35B | 76.89B | 65.89B | 57.12B |
Cash Flow | |||||
| Free Cash Flow | 12.62B | 14.73B | 15.86B | -14.60B | 8.22B |
| Operating Cash Flow | 27.03B | 29.83B | 31.68B | 6.70B | 19.71B |
| Investing Cash Flow | -16.53B | -20.06B | -16.75B | -22.56B | -11.11B |
| Financing Cash Flow | -12.03B | -7.92B | -8.17B | 9.03B | -5.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥102.41B | 27.62 | 7.99% | 3.89% | -0.51% | 14.01% | |
71 Outperform | ¥69.52B | 3.34 | ― | 2.88% | 2.48% | 10.65% | |
69 Neutral | ¥24.93B | -17.01 | ― | 2.18% | 5.26% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
62 Neutral | ¥44.33B | 3.72 | ― | 1.81% | 1.29% | 27.31% | |
61 Neutral | ¥81.75B | 19.64 | 9.07% | 3.61% | 2.90% | 13.95% | |
59 Neutral | ¥451.24B | 15.57 | 6.03% | 1.81% | -0.75% | 33.35% |